US-based OKAVA Pharmaceuticals started testing a long-acting implant, designed to deliver the medicine continuously for up to ...

USA News Group - News Commentary - Depression remains one of the most stubborn problems in modern medicine, and the numbers ...

Space missions come with certain dangers, including a lack of supplies. But a new study has shown that astronauts may be able ...

When Chinese drug developers need to see exactly how an experimental medicine binds to its target protein, or materials ...

The two-year treatment targeting protein production by disease-causing mutations dramatically reduced seizures and sparked ...

The Indian government has published a 10-year national bioeconomy roadmap sector, which includes a focus on alternative ...

The company says recent investments in manufacturing and overseas expansion should start paying off over the next few ...

Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogenderived treatments for Alcohol Use Disorder (AUD), addiction, and weight ...

Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers.

Kalshi, the next-generation financial exchange, today announced a partnership with public intelligence company AppliedXL to launch a pilot suite of prediction markets on clinical trial outcomes and ...

The Energy Regulatory Commission (ERC) has temporarily suspended the power delivery service (PDS) charges for qualified energy storage systems (ESS) to support grid reliability. The commission noted ...

London hosted the fifth meeting of the Economic and Social Pillar of the Saudi-UK Strategic Partnership Council, co-chaired ...